Umbrella Review of MSC Therapy Outcomes in Diabetes
MSC therapy resulted in significant reductions in HbA1c levels and insulin requirements, with improvements persisting across 3-, 6-, and 12-month follow-ups for patients with type 2 diabetes mellitus